IGF1 and Laron syndrome: Notably, individuals with Laron syndrome also exhibit an almost complete absence of cancer, further suggesting that reduced IGF-1 signaling may confer protective effects against both neurodegeneration and tumorigenesis (Nashiro et al., 2017).